Login

James P. Scriven, CEO of IDB Invest, shares insights on Latin American finance and development with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
CEO Juha Saarela Highlights Key Drivers of Puuilo's Q1 Success in New Fiscal Year | Juha Saarela, CEO, Puuil OYj.
00:10:00
Powering Heavy Duty Transport: Batteries, Hydrogen, Bio-Fuels | Gerrit Marx - CEO of Iveco Group
00:10:00
Learn about Pictet Asset Management USA from its CEO, Elizabeth Dillon, and delve deeper into our offerings on our website.
00:10:00
To apply to IVU and prepare for the job interview, submit your application online with relevant documents and prepare by researching the company and practicing common interview questions.|Prof. Dr Herbert Sonntag of Chairman-Supervisory Board of IVU Traff
00:10:00
address large-scale problems in human and environmental health|Gareth Asten,Managing Partner,Acre Venture Partners
00:10:00
Innovative Female Coveralls Designed for Safety and Comfort in Mining
00:00:00
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
00:10:00
Romeo's Gold Resources: Exploring BC's Golden Triangle
00:10:00
Revolutionizing REITs: A Deep Dive into LTC Financing with Pam Kessler on Bridge the Gap Podcast
00:10:00
invests in consumer technology with a particular interest in consumer software|Gautam Gupta,General Partner, TCV
00:10:00
"Navigating Pharmacy Compliance in Telehealth: Insights from Ann Hollenbeck" | ANN T. HOLLENBECK - Partner-in-Charge Detroit, Jones Day
00:00:00
Amir R. Khan, M.D. Ophthalmologist, Mayo Clinic

© 2017 - Neuhu+